Charles Cherington has bought stock on 6 days since Dec 2022
10% owner at Ernexa Therapeutics Inc., and 1 other company
SEC CIK 0001448698 · Filings on SEC.gov ↗
Charles Cherington's record
3 months after each buy, from the first price a copier could get.
4 buys since 2022 with 3 months of prices.
Companies
Every filing
6 filings since Dec 2022, newest first
Ernexa Therapeutics Inc.
10% owner
Ernexa Therapeutics Inc.
10% owner
Eterna Therapeutics Inc.
10% owner
Comera Life Sciences Holdings, Inc.
10% owner
Comera Life Sciences Holdings, Inc.
10% owner
Eterna Therapeutics Inc.
Director and 10% owner
About Charles Cherington
Charles Cherington is a seasoned private equity executive and the co-founder and Managing Partner of Ara Partners, a global private equity firm focused on industrial decarbonization investments, established in 2017.( He co-heads the firm with Troy Thacker and serves on its Investment Committee, bringing over 30 years of experience in the industrial, energy, and chemical sectors, with more than 50 transactions executed.( Previously, Cherington co-founded and managed Intervale Capital (2006-2017), founded Cherington Capital (2002-2006), and was a partner at Paratus Capital Management (1999-2004), alongside early roles at Lochridge & Company and Credit Suisse First Boston.( He holds a B.A. in History from Wesleyan University and an M.B.A. with honors from the University of Chicago.(
As a prominent investor, Cherington is a 10% owner of Ernexa Therapeutics Inc. (ERNA), holding approximately 2,777,318 shares as of June 2025, valued at over $7 million, reflecting recent insider trading activity.( His portfolio also includes significant stakes in Comera Life Sciences Holdings Inc. (CMRA) and past directorships such as at Beard Energy Transition Acquisition Corp. (BRD).( Beyond finance, Cherington is active in land conservation, serving on The Conservation Fund's Board of Directors.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.